Charles Schwab Investment Management Inc Ionis Pharmaceuticals Inc Transaction History

Charles Schwab Investment Management Inc

$519 Billion
Q2 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,328,106 shares of IONS stock, worth $56.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,328,106

Previous 1,301,368 2.05%

Holding current value

$56.3 Million

Previous $56.4 Million 12.2%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$36.45 - $47.7 $974,600 - $1.28 Million	26,738 Added 2.05%	1,328,106 $63.3 Million
Q1 2024 May 08, 2024	BUY	$42.03 - $53.55 $1.09 Million - $1.39 Million	26,049 Added 2.04%	1,301,368 $56.4 Million
Q4 2023 Feb 06, 2024	BUY	$43.39 - $51.63 $1.43 Million - $1.7 Million	33,012 Added 2.66%	1,275,319 $64.5 Million
Q3 2023 Nov 08, 2023	BUY	$38.5 - $47.13 $1.66 Million - $2.03 Million	43,087 Added 3.59%	1,242,307 $56.4 Million
Q2 2023 Aug 09, 2023	BUY	$34.73 - $43.33 $445,481 - $555,793	12,827 Added 1.08%	1,199,220 $49.2 Million
Q1 2023 May 11, 2023	SELL	$33.58 - $41.2 $2.35 Million - $2.88 Million	-69,875 Reduced 5.56%	1,186,393 $42.4 Million
Q4 2022 Feb 13, 2023	BUY	$37.12 - $46.52 $2 Million - $2.51 Million	53,922 Added 4.48%	1,256,268 $47.4 Million
Q3 2022 Nov 14, 2022	BUY	$36.54 - $48.66 $1.77 Million - $2.35 Million	48,321 Added 4.19%	1,202,346 $53.2 Million
Q2 2022 Aug 15, 2022	BUY	$31.71 - $43.0 $513,638 - $696,514	16,198 Added 1.42%	1,154,025 $42.7 Million
Q1 2022 May 13, 2022	BUY	$29.88 - $37.04 $1.33 Million - $1.64 Million	44,388 Added 4.06%	1,137,827 $42.1 Million
Q4 2021 Feb 11, 2022	BUY	$25.61 - $35.1 $607,136 - $832,115	23,707 Added 2.22%	1,093,439 $33.3 Million
Q3 2021 Nov 16, 2021	BUY	$33.54 - $40.55 $11.9 Million - $14.4 Million	355,772 Added 49.83%	1,069,732 $35.9 Million
Q2 2021 Aug 16, 2021	BUY	$34.54 - $47.25 $603,206 - $825,174	17,464 Added 2.51%	713,960 $28.5 Million
Q1 2021 May 17, 2021	BUY	$42.51 - $63.78 $216,248 - $324,448	5,087 Added 0.74%	696,496 $31.3 Million
Q4 2020 Feb 16, 2021	BUY	$45.3 - $60.27 $462,286 - $615,055	10,205 Added 1.5%	691,409 $39.1 Million
Q3 2020 Nov 13, 2020	BUY	$47.45 - $62.95 $3.07 Million - $4.08 Million	64,735 Added 10.5%	681,204 $32.3 Million
Q2 2020 Aug 14, 2020	BUY	$46.85 - $61.05 $270,324 - $352,258	5,770 Added 0.94%	616,469 $36.3 Million
Q1 2020 May 15, 2020	BUY	$41.6 - $63.4 $560,518 - $854,251	13,474 Added 2.26%	610,699 $28.9 Million
Q4 2019 Feb 07, 2020	BUY	$53.85 - $65.27 $491,435 - $595,654	9,126 Added 1.55%	597,225 $36.1 Million
Q3 2019 Nov 08, 2019	SELL	$59.06 - $72.15 $1.68 Million - $2.05 Million	-28,414 Reduced 4.61%	588,099 $35.2 Million
Q2 2019 Aug 09, 2019	BUY	$62.09 - $86.14 $2.11 Million - $2.93 Million	33,997 Added 5.84%	616,513 $39.6 Million
Q1 2019 May 14, 2019	BUY	$52.92 - $81.17 $1.99 Million - $3.06 Million	37,679 Added 6.92%	582,516 $47.3 Million
Q4 2018 Feb 14, 2019	BUY	$43.37 - $59.54 $827,586 - $1.14 Million	19,082 Added 3.63%	544,837 $29.5 Million
Q3 2018 Nov 13, 2018	BUY	$42.88 - $53.7 $3.07 Million - $3.84 Million	71,526 Added 15.75%	525,755 $27.1 Million
Q2 2018 Aug 08, 2018	BUY	$40.53 - $50.7 $1.11 Million - $1.39 Million	27,355 Added 6.41%	454,229 $18.9 Million
Q1 2018 May 07, 2018	BUY	$44.08 - $55.05 $1.1 Million - $1.37 Million	24,894 Added 6.19%	426,874 $18.8 Million
Q4 2017 Jan 17, 2018	BUY	$50.3 - $64.39 $1.02 Million - $1.3 Million	20,246 Added 5.3%	401,980 $20.2 Million
Q3 2017 Nov 13, 2017	BUY	$45.56 - $59.57 $17.4 Million - $22.7 Million	381,734	381,734 $19.4 Million

Others Institutions Holding IONS

# of Institutions

394

Shares Held

125M

Call Options Held

2.25M

Put Options Held

510K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $6.01B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Ionis Pharmaceuticals Inc Transaction History